Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

Summary

The purpose of this study is: * To investigate CYP2C9 inhibition by BIA 5-1058 through the assessment of its effect on the Pharmacokinetic (PK) of S-warfarin, a substrate of CYP2C9. * To assess the effect of warfarin on the PK of BIA 5-1058.

Timeline

Start

2018-02-23

Primary completion

2018-05-23

Completion

2018-05-23

Drugs

Indications